Craneware plc (AIM:CRW)
London · Delayed Price · Currency is GBP · Price in GBX 1,576.00
+8.00 (0.51%)
May 7, 2026, 4:37 PM GMT
Craneware Market Cap
Craneware has a market cap or net worth of 538.64 million as of May 7, 2026. Its market cap has decreased by -2.65% in one year.
Market Cap
538.64M
Enterprise Value
528.20M
Revenue
157.02M
Ranking
n/a
PE Ratio
33.61
Stock Price
1,576.00
Market Cap Chart
Since September 13, 2007, Craneware's market cap has increased from 27.00M to 538.64M, an increase of 1,895.31%. That is a compound annual growth rate of 17.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 538.64M | -20.42% |
| Dec 31, 2025 | 676.88M | -8.39% |
| Dec 31, 2024 | 738.88M | 20.69% |
| Dec 29, 2023 | 612.23M | -3.93% |
| Dec 30, 2022 | 637.29M | -26.03% |
| Dec 31, 2021 | 861.52M | 41.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 209.57B |
| GSK plc | 75.89B |
| Haleon | 30.56B |
| Smith & Nephew | 9.80B |
| CVS Group | 820.83M |
| Oxford Biomedica | 716.94M |
| Spire Healthcare Group | 658.58M |
| Allergy Therapeutics | 649.08M |